Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): A multicentre,...
Regimens based on ibrutinib alone and lenalidomide and rituximab in combination show high activity in patients with relapsed or refractory mantle cell lymphoma. We...
Making Ultrasound More Accessible: GE Healthcare’s New Versana Essential Combines Quality and Affordability
Helping clinicians expand diagnostic capabilities and increase patient satisfaction, GE Healthcare today unveiled a new ultrasound system with impeccable image quality and advanced yet...
NYU Langone Health Launches New Lung Transplant Program
NYU Langone’s Transplant Institute has launched a new lung transplant program, the third program of its kind in the greater New York City area,...
Mount Sinai Health System Expands Innovative Care in Florida
Mount Sinai Health System in New York announced the opening of a new state-of-the-art medical practice in Palm Beach, Florida, bringing world-class, innovative care...
South Nassau Communities Hospital Officially Partners With Mount Sinai
South Nassau Communities Hospital officially became the Long Island flagship health care institution in the Mount Sinai Health System after a unanimous vote by...
Real Time Image Gating Motion Management for Proton Therapy System clearance Hitachi Received FDA...
Hitachi, Ltd and Hokkaido University announced that it has obtained U.S. FDA 510(k) clearance on December 26, 2017 for the commercialization of "Real Time...
SonoSite supports first pan-European ESRA training
Saturday the 27th of January 2018 marks the first ESRA European Day of Regional Anaesthesia, delivered simultaneously in over 20 training hubs across the...
Nuance Unveils AI-Powered Dragon Medical Practice Edition 4
Nuance Communications, Inc. announced the release of Dragon Medical Practice Edition 4, the latest locally installed version of Nuance’s industry-leading clinical speech recognition solution...
Check-Cap Receives CE Mark Approval for C-Scan®
Check-Cap Ltd. a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, announced it has...
FDA Approves XGEVA for the prevention of Skeletal-Related Events in patients with multiple myeloma
Amgen announced that the US FDA has approved the supplemental Biologics License Application (sBLA) for Xgeva (denosumab) to expand the currently approved indication for...
